+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Selecta Biosciences - logo

Selecta Biosciences was founded in 2007 and is headquartered in Watertown, Massachusetts. It is a biopharmaceutical company, they create biological therapies that fight against unwanted immune responses. Selecta Biosciences specialise in Synthetic Vaccine Particles (SVP™) technology platform. They use this treatment to fight rare and serious diseases. Selectas current pipeline includes: SVP- enabled enzyme, oncology and gene therapies.

Ornithine Transcarbamylase Deficiency Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Ornithine Transcarbamylase Deficiency Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • July 2023
  • 92 Pages
  • Global
From
Pompe Disease - Pipeline Insight, 2024 - Product Thumbnail Image

Pompe Disease - Pipeline Insight, 2024

  • Clinical Trials
  • November 2024
  • 80 Pages
  • Global
From
Comprehensive Report on Selecta Biosciences Inc, including SWOT, PESTLE and Business Model Canvas - Product Thumbnail Image

Comprehensive Report on Selecta Biosciences Inc, including SWOT, PESTLE and Business Model Canvas

  • SWOT Analysis
  • August 2023
  • 90 Pages
From
Loading Indicator